{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:40:22Z","timestamp":1789497622202,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T00:00:00Z","timestamp":1609545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81572270"],"award-info":[{"award-number":["81572270"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81730103"],"award-info":[{"award-number":["81730103"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81473283"],"award-info":[{"award-number":["81473283"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["81973398"],"award-info":[{"award-number":["81973398"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Major Projects for Science and Technology Development from Science and Technology Ministry of China","award":["2012ZX09506001-004"],"award-info":[{"award-number":["2012ZX09506001-004"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program","doi-asserted-by":"crossref","award":["2016YFC0905001"],"award-info":[{"award-number":["2016YFC0905001"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013314","name":"111 project","doi-asserted-by":"crossref","award":["B16047"],"award-info":[{"award-number":["B16047"]}],"id":[{"id":"10.13039\/501100013314","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00432-020-03476-4","type":"journal-article","created":{"date-parts":[[2021,1,2]],"date-time":"2021-01-02T11:03:07Z","timestamp":1609585387000},"page":"725-737","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Impact of STAT1 polymorphisms on crizotinib-induced hepatotoxicity in ALK-positive non-small cell lung cancer patients"],"prefix":"10.1007","volume":"147","author":[{"given":"Shuang","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changzheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanfei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7158-3878","authenticated-orcid":false,"given":"Likun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,2]]},"reference":[{"key":"3476_CR1","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Abecasis GR (2015) A global reference for human genetic variation. Nature 526:68\u201374","journal-title":"Nature"},{"key":"3476_CR2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.14712\/fb2013059020076","volume":"59","author":"K Chalupsky","year":"2013","unstructured":"Chalupsky K, Kanchev I, Zbodakova O, Buryova H, Jirouskova M, Korinek V, Gregor M, Sedlacek R (2013) ADAM10\/17-dependent release of soluble c-Met correlates with hepatocellular damage. Folia Biol (Praha) 59:76\u201386","journal-title":"Folia Biol (Praha)"},{"key":"3476_CR3","doi-asserted-by":"publisher","first-page":"8857","DOI":"10.1038\/s41598-018-27214-6","volume":"8","author":"Y Chang","year":"2018","unstructured":"Chang Y, Park H, Yang HJ, Lee S, Lee KY, Kim TS, Jung J, Shin JM (2018) Cancer drug response profile scan (CDRscan): a deep learning model that predicts drug effectiveness from cancer genomic signature. Sci Rep 8:8857","journal-title":"Sci Rep"},{"key":"3476_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, Clark NR, Ma\u2019Ayan A (2013) Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinform 14:128","journal-title":"BMC Bioinform"},{"key":"3476_CR5","doi-asserted-by":"publisher","first-page":"e0144490","DOI":"10.1371\/journal.pone.0144490","volume":"10","author":"S Haider","year":"2015","unstructured":"Haider S, Rahman R, Ghosh S, Pal R (2015) A Copula based approach for design of multivariate random forests for drug sensitivity prediction. PLoS ONE 10:e0144490","journal-title":"PLoS ONE"},{"key":"3476_CR6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1038\/ng1966","volume":"39","author":"ND Heintzman","year":"2007","unstructured":"Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, Hawkins RD, Barrera LO, Van Calcar S, Qu C, Ching KA, Wang W, Weng Z, Green RD, Crawford GE, Ren B (2007) Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39:311\u2013318","journal-title":"Nat Genet"},{"key":"3476_CR7","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","volume":"166","author":"F Iorio","year":"2016","unstructured":"Iorio F, Knijnenburg TA, Vis DJ, Bignell GR, Menden MP, Schubert M, Aben N, Goncalves E, Barthorpe S, Lightfoot H, Cokelaer T, Greninger P, van Dyk E, Chang H, de Silva H, Heyn H, Deng X, Egan RK, Liu Q, Mironenko T, Mitropoulos X, Richardson L, Wang J, Zhang T, Moran S, Sayols S, Soleimani M, Tamborero D, Lopez-Bigas N, Ross-Macdonald P, Esteller M, Gray NS, Haber DA, Stratton MR, Benes CH, Wessels L, Saez-Rodriguez J, McDermott U, Garnett MJ (2016) A landscape of pharmacogenomic interactions in cancer. Cell 166:740\u2013754","journal-title":"Cell"},{"key":"3476_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s12032-018-1213-5","volume":"35","author":"D Jung","year":"2018","unstructured":"Jung D, Han JM, Yee J, Kim JY, Gwak HS (2018) Factors affecting crizotinib-induced hepatotoxicity in non-small cell lung cancer patients. Med Oncol 35:154","journal-title":"Med Oncol"},{"key":"3476_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.critrevonc.2018.11.004","volume":"134","author":"L Kassem","year":"2019","unstructured":"Kassem L, Shohdy KS, Lasheen S, Abdel-Rahman O, Ali A, Abdel-Malek RR (2019) Safety issues with the ALK inhibitors in the treatment of NSCLC: a systematic review. Crit Rev Oncol Hematol 134:56\u201364","journal-title":"Crit Rev Oncol Hematol"},{"key":"3476_CR10","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.1634\/theoncologist.2014-0241","volume":"19","author":"D Kazandjian","year":"2014","unstructured":"Kazandjian D, Blumenthal GM, Chen HY, He K, Patel M, Justice R, Keegan P, Pazdur R (2014) FDA approval summary: crizotinib for the treatment of metastatic non-small cell lung cancer with anaplastic lymphoma kinase rearrangements. Oncologist 19:e5-11","journal-title":"Oncologist"},{"key":"3476_CR11","doi-asserted-by":"publisher","first-page":"G761","DOI":"10.1152\/ajpgi.00224.2003","volume":"285","author":"WH Kim","year":"2003","unstructured":"Kim WH, Hong F, Radaeva S, Jaruga B, Fan S, Gao B (2003) STAT1 plays an essential role in LPS\/D-galactosamine-induced liver apoptosis and injury. Am J Physiol Gastrointest Liver Physiol 285:G761\u2013G768","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3476_CR12","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, Koplev S, Jenkins SL, Jagodnik KM, Lachmann A, McDermott MG, Monteiro CD, Gundersen GW, Ma\u2019Ayan A (2016) Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44:W90\u2013W97","journal-title":"Nucleic Acids Res"},{"key":"3476_CR13","doi-asserted-by":"publisher","first-page":"9480","DOI":"10.18632\/oncotarget.23840","volume":"9","author":"B Liu","year":"2018","unstructured":"Liu B, Yuan M, Sun Y, Cheng Z, Zhang Z, Hou S, Wang X, Liu J (2018) Incidence and risk of hepatic toxicities associated with anaplastic lymphoma kinase inhibitors in the treatment of non-small-cell lung cancer: a systematic review and meta-analysis. Oncotarget 9:9480\u20139488","journal-title":"Oncotarget"},{"key":"3476_CR14","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1136\/gutjnl-2019-318372","volume":"69","author":"A Marti-Rodrigo","year":"2019","unstructured":"Marti-Rodrigo A, Alegre F, Moragrega AB, Garcia-Garcia F, Marti-Rodrigo P, Fernandez-Iglesias A, Gracia-Sancho J, Apostolova N, Esplugues JV, Blas-Garcia A (2019) Rilpivirine attenuates liver fibrosis through selective STAT1-mediated apoptosis in hepatic stellate cells. Gut 69:920","journal-title":"Gut"},{"key":"3476_CR15","doi-asserted-by":"publisher","first-page":"e61318","DOI":"10.1371\/journal.pone.0061318","volume":"8","author":"MP Menden","year":"2013","unstructured":"Menden MP, Iorio F, Garnett M, McDermott U, Benes CH, Ballester PJ, Saez-Rodriguez J (2013) Machine learning prediction of cancer cell sensitivity to drugs based on genomic and chemical properties. PLoS ONE 8:e61318","journal-title":"PLoS ONE"},{"key":"3476_CR16","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/jjco\/hyu086","volume":"44","author":"Y Sato","year":"2014","unstructured":"Sato Y, Fujimoto D, Shibata Y, Seo R, Suginoshita Y, Imai Y, Tomii K (2014) Fulminant hepatitis following crizotinib administration for ALK-positive non-small-cell lung carcinoma. Jpn J Clin Oncol 44:872\u2013875","journal-title":"Jpn J Clin Oncol"},{"key":"3476_CR17","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1056\/NEJMoa1214886","volume":"368","author":"AT Shaw","year":"2013","unstructured":"Shaw AT, Kim DW, Nakagawa K, Seto T, Crino L, Ahn MJ, De Pas T, Besse B, Solomon BJ, Blackhall F, Wu YL, Thomas M, O\u2019Byrne KJ, Moro-Sibilot D, Camidge DR, Mok T, Hirsh V, Riely GJ, Iyer S, Tassell V, Polli A, Wilner KD, Janne PA (2013) Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med 368:2385\u20132394","journal-title":"N Engl J Med"},{"key":"3476_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/nsmb.2784","volume":"21","author":"E Smith","year":"2014","unstructured":"Smith E, Shilatifard A (2014) Enhancer biology and enhanceropathies. Nat Struct Mol Biol 21:210\u2013219","journal-title":"Nat Struct Mol Biol"},{"key":"3476_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nature05945","volume":"448","author":"M Soda","year":"2007","unstructured":"Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, Fujiwara S, Watanabe H, Kurashina K, Hatanaka H, Bando M, Ohno S, Ishikawa Y, Aburatani H, Niki T, Sohara Y, Sugiyama Y, Mano H (2007) Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448:561\u2013566","journal-title":"Nature"},{"key":"3476_CR20","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","volume":"371","author":"BJ Solomon","year":"2014","unstructured":"Solomon BJ, Mok T, Kim DW, Wu YL, Nakagawa K, Mekhail T, Felip E, Cappuzzo F, Paolini J, Usari T, Iyer S, Reisman A, Wilner KD, Tursi J, Blackhall F (2014) First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med 371:2167\u20132177","journal-title":"N Engl J Med"},{"key":"3476_CR21","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ajhg.2015.05.016","volume":"97","author":"G Trynka","year":"2015","unstructured":"Trynka G, Westra HJ, Slowikowski K, Hu X, Xu H, Stranger BE, Klein RJ, Han B, Raychaudhuri S (2015) Disentangling the effects of colocalizing genomic annotations to functionally prioritize non-coding variants within complex-trait loci. Am J Hum Genet 97:139\u2013152","journal-title":"Am J Hum Genet"},{"key":"3476_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.lungcan.2015.12.010","volume":"93","author":"RM van Geel","year":"2016","unstructured":"van Geel RM, Hendrikx JJ, Vahl JE, van Leerdam ME, van den Broek D, Huitema AD, Beijnen JH, Schellens JH, Burgers SA (2016) Crizotinib-induced fatal fulminant liver failure. Lung Cancer 93:17\u201319","journal-title":"Lung Cancer"},{"key":"3476_CR23","doi-asserted-by":"publisher","first-page":"6119","DOI":"10.1038\/s41388-018-0383-0","volume":"37","author":"Y Yang","year":"2018","unstructured":"Yang Y, Wu XQ, Li WX, Huang HM, Li HD, Pan XY, Li XF, Huang C, Meng XM, Zhang L, Lv XW, Wang H, Li J (2018) PSTPIP2 connects DNA methylation to macrophage polarization in CCL4-induced mouse model of hepatic fibrosis. Oncogene 37:6119\u20136135","journal-title":"Oncogene"},{"key":"3476_CR24","doi-asserted-by":"publisher","first-page":"31619","DOI":"10.1038\/srep31619","volume":"6","author":"H Yuan","year":"2016","unstructured":"Yuan H, Paskov I, Paskov H, Gonzalez AJ, Leslie CS (2016) Multitask learning improves prediction of cancer drug sensitivity. Sci Rep 6:31619","journal-title":"Sci Rep"},{"key":"3476_CR25","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1101\/gr.122382.111","volume":"21","author":"GE Zentner","year":"2011","unstructured":"Zentner GE, Tesar PJ, Scacheri PC (2011) Epigenetic signatures distinguish multiple classes of enhancers with distinct cellular functions. Genome Res 21:1273\u20131283","journal-title":"Genome Res"},{"key":"3476_CR26","doi-asserted-by":"publisher","first-page":"44910","DOI":"10.1038\/srep44910","volume":"7","author":"H Zhang","year":"2017","unstructured":"Zhang H, Chen F, Fan X, Lin C, Hao Y, Wei H, Lin W, Jiang Y, He F (2017) Quantitative proteomic analysis on activated hepatic stellate cells reversion reveal STAT1 as a key regulator between liver fibrosis and recovery. Sci Rep 7:44910","journal-title":"Sci Rep"},{"key":"3476_CR27","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.12998\/wjcc.v7.i9.1080","volume":"7","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Xu YY, Chen Y, Li JN, Wang Y (2019) Crizotinib-induced acute fatal liver failure in an Asian ALK -positive lung adenocarcinoma patient with liver metastasis: a case report. World J Clin Cases 7:1080\u20131086","journal-title":"World J Clin Cases"},{"key":"3476_CR28","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/nmeth.1772","volume":"8","author":"X Zhou","year":"2011","unstructured":"Zhou X, Maricque B, Xie M, Li D, Sundaram V, Martin EA, Koebbe BC, Nielsen C, Hirst M, Farnham P, Kuhn RM, Zhu J, Smirnov I, Kent WJ, Haussler D, Madden PA, Costello JF, Wang T (2011) The human epigenome browser at Washington University. Nat Methods 8:989\u2013990","journal-title":"Nat Methods"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03476-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-020-03476-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-020-03476-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T15:27:04Z","timestamp":1724167624000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-020-03476-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,2]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["3476"],"URL":"https:\/\/doi.org\/10.1007\/s00432-020-03476-4","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,2]]},"assertion":[{"value":"18 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the Ethical Committee of Sun Yat-Sen University Cancer Center (B2015-080-01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all participating subjects. This trial was registered at ClinicalTrials.gov. (NCT02708667).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}